Nortrel 7/7/7 - 28 Day Oral Contraceptive (norethindrone and ethinyl estradiol tablets, USP)
July 11, 2003
Audience: Pharmacists, reproductive health professionals, and consumers
Barr Laboratories announced a voluntary recall of 3 lots of its Nortrel 7/7/7 – 28 day (norethindrone and ethinyl estradiol tablets, USP) oral contraceptive product. The recall involves Lot Numbers 290122001, 290122002 and 290122003 and is being implemented because two individuals notified the company that the color-coded tablets in their product blister cards were in an improper sequence. Any woman who has received a Nortrel 7/7/7 – 28 day blister card with tablets in the wrong sequence could be at an increased risk of pregnancy. In addition, changes to the menstrual cycle, including delayed bleeding, irregular bleeding or spotting, may occur.[July 9, 2003 Press Release - Barr Laboratories] PDF Format
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.